Literature DB >> 3802027

Distribution of axillary node metastases by level of invasion. An analysis of 539 cases.

U Veronesi, F Rilke, A Luini, V Sacchini, V Galimberti, T Campa, E Dei Bei, M Greco, A Magni, M Merson.   

Abstract

Five hundred and thirty-nine patients with carcinoma of the breast treated with total axillary dissection and with positive axillary nodes were evaluated. The total number of lymph nodes removed was 11,082, with an average of 20.5 nodes per patient. The average number of lymph nodes at the first level was 13.8, at the second level 4.5, at the third level 2.2. The average number of nodes was 20.7 in cases treated with Halsted mastectomy, 20.9 with total mastectomy and axillary dissection, 20.3 with quadrantectomy and axillary dissection. Of 3259 metastatic nodes, 64 were site of micrometastases; 797 were partially involved, 441 were totally involved and 1957 were site of metastases with extracapsular invasion. In 314 (58.2%) the first level only was involved, in 117 cases (21.7%) metastases were present at the first and second level, whereas in 88 cases (16.3%) all the three levels were sites of metastases. Only 20 cases showed skipping distribution. In 1.5% of the cases the first level was skipped by metastases, in 0.4% the first nodes of the first level are clear the chances that metastatic nodes are present at the second and third levels are negligible. When the nodes at the first level are positive, the chances that metastases are also present at the higher levels are of the order of 40.0%.

Entities:  

Mesh:

Year:  1987        PMID: 3802027     DOI: 10.1002/1097-0142(19870215)59:4<682::aid-cncr2820590403>3.0.co;2-z

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  26 in total

1.  Effect of the use of vital dye, lymphoscintigraphy, or a combination for axillary lymphatic mapping and sentinel node biopsy in breast cancer.

Authors:  Giovanni d'Eredita; Gabriella Serio; Marino Mele; Carmela Giardina; Martino Martellotta; Filippo Ferrarese
Journal:  World J Surg       Date:  2002-02-20       Impact factor: 3.352

2.  Comparative morbidity of axillary lymph node dissection and the sentinel lymph node technique: implications for patients with breast cancer.

Authors:  Allan W Silberman; Carie McVay; Jason S Cohen; Jack F Altura; Sandra Brackert; Gregory P Sarna; Daphne Palmer; Albert Ko; Leslie Memsic
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

3.  A multivariate study of the relationship between regional lymph node metastases and prognosis in patients with operable breast cancer.

Authors:  M Noguchi; T Taniya; N Koyasaki; N Ohta; I Miyazaki
Journal:  Jpn J Surg       Date:  1991-11

4.  Complications of level I and II axillary dissection in the treatment of carcinoma of the breast.

Authors:  D F Roses; A D Brooks; M N Harris; R L Shapiro; J Mitnick
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

5.  Intraoperative assessment of axillary lymph node metastases in operable breast cancer.

Authors:  M Noguchi; M Minami; M Earashi; T Taniya; I Miyazaki; Y Mizukami; A Nonomura
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

6. 

Authors:  J C Rageth
Journal:  Arch Gynecol Obstet       Date:  1995-12       Impact factor: 2.344

7.  Sentinel lymph node detection with large human serum albumin colloid particles in breast cancer.

Authors:  S Mirzaei; M Rodrigues; B Hoffmann; P Knoll; M Riegler-Keil; W Kreuzer; H Salzer; H Köhn; A Polyák; G A Jánoki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-04       Impact factor: 9.236

8.  Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.

Authors:  I C Smith; K N Ogston; P Whitford; F W Smith; P Sharp; M Norton; I D Miller; A K Ah-See; S D Heys; J A Jibril; O Eremin
Journal:  Ann Surg       Date:  1998-08       Impact factor: 12.969

9.  Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer.

Authors:  G Gruber; B F Cole; M Castiglione-Gertsch; S B Holmberg; J Lindtner; R Golouh; J Collins; D Crivellari; B Thürlimann; E Simoncini; M F Fey; R D Gelber; A S Coates; K N Price; A Goldhirsch; G Viale; B A Gusterson
Journal:  Ann Oncol       Date:  2008-04-02       Impact factor: 32.976

10.  Lymphatic mapping and sentinel lymphadenectomy for breast cancer.

Authors:  A E Giuliano; D M Kirgan; J M Guenther; D L Morton
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.